ES2137138B1 - Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos. - Google Patents
Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos.Info
- Publication number
- ES2137138B1 ES2137138B1 ES009801129A ES9801129A ES2137138B1 ES 2137138 B1 ES2137138 B1 ES 2137138B1 ES 009801129 A ES009801129 A ES 009801129A ES 9801129 A ES9801129 A ES 9801129A ES 2137138 B1 ES2137138 B1 ES 2137138B1
- Authority
- ES
- Spain
- Prior art keywords
- preparation
- medicines
- application
- treatment
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Derivados de pirazolinas, su preparación y su aplicación como medicamentos. La presente invención se refiere a nuevos derivados de pirazolinas de fórmula general (I), así como a sus sales fisiológicamente aceptables, a los procedimientos para su preparación, a su aplicación como medicamentos en terapéutica humana y/o veterinaria y a las composiciones farmacéuticas que los contienen. Los nuevos compuestos objeto de la presente invención pueden ser utilizados en la industria farmacéutica como intermedios y para la preparación de medicamentos. En particular se pueden utilizar par la elaboración de medicamentos para el tratamiento de la inflamación y de otros trastornos asociados con la inflamación y otros procesos mediados por la ciclooxigenasa-2, por ejemplo, la artritis, el tratamiento del dolor o tratamiento de la fiebre.
Priority Applications (34)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009801129A ES2137138B1 (es) | 1998-05-29 | 1998-05-29 | Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos. |
US09/701,276 US6353117B1 (en) | 1998-05-29 | 1999-05-27 | Pyrazoline derivatives, their preparation and application as medicaments |
JP2000552096A JP4633928B2 (ja) | 1998-05-29 | 1999-05-27 | ピラゾリン誘導体、その調製及び薬剤としての適用 |
TW88108709A TW572898B (en) | 1998-05-29 | 1999-05-27 | Pyrazoline derivatives, their preparation and their application as medicament |
GEAP19995706A GEP20043237B (en) | 1998-05-29 | 1999-05-27 | Pyrazoline Derivatives, Method for Their Preparation and Compositions Containing Them for Treatment of Diseases Mediated by Cyclooxygenase-2 |
CNB998081116A CN1189459C (zh) | 1998-05-29 | 1999-05-27 | 吡唑啉衍生物、它们的制备方法和作为药物的应用 |
KR1020007013447A KR100603666B1 (ko) | 1998-05-29 | 1999-05-27 | 피라졸린 유도체, 그 제조방법 및 약으로서의 용도 |
HU0102102A HUP0102102A3 (en) | 1998-05-29 | 1999-05-27 | Pyrazoline derivatives, their preparation, pharmaceutical compositions containing them and their use |
NZ508990A NZ508990A (en) | 1998-05-29 | 1999-05-27 | Pyrazoline derivatives, their preparation and application as medicaments |
SI9920042A SI20580B (sl) | 1998-05-29 | 1999-05-27 | Derivati pirazolina, njihova priprava in njihova uporaba kot zdravila |
PCT/ES1999/000156 WO1999062884A1 (es) | 1998-05-29 | 1999-05-27 | Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos |
RU2000133231/04A RU2233272C2 (ru) | 1998-05-29 | 1999-05-27 | Производные пиразолина, способы их получения и фармацевтическая композиция |
PT99922192T PT1083171E (pt) | 1998-05-29 | 1999-05-27 | Derivados de pirazolina sua preparacao e aplicacao como medicamentos |
ES99922192T ES2221382T3 (es) | 1998-05-29 | 1999-05-27 | Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos. |
US10/229,880 USRE38963E1 (en) | 1998-05-29 | 1999-05-27 | Pyrazoline derivatives, their preparation and application as medicaments |
CZ20004418A CZ298391B6 (cs) | 1998-05-29 | 1999-05-27 | Derivát pyrazolinu, zpusob jeho prípravy, jeho použití a farmaceutický prostredek, který ho obsahuje |
AT99922192T ATE265437T1 (de) | 1998-05-29 | 1999-05-27 | Pyrazoline, ihre herstellung und verwendung als medikamente |
CO99032824A CO5031241A1 (es) | 1998-05-29 | 1999-05-27 | Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos |
DK99922192T DK1083171T3 (da) | 1998-05-29 | 1999-05-27 | Pyrazolinderivater, deres fremstilling og anvendelse som medikamenter |
CA002333475A CA2333475C (en) | 1998-05-29 | 1999-05-27 | Derivatives of pyrazolines, their preparation and their application as medicaments |
ARP990102513A AR018402A1 (es) | 1998-05-29 | 1999-05-27 | DERIVADO DE PIRAZOLINA, PROCEDIMIENTO DE PREPARACIoN Y COMPOSICION FARMACEUTICA |
DE69916828T DE69916828T2 (de) | 1998-05-29 | 1999-05-27 | Pyrazoline, ihre herstellung und verwendung als medikamente |
EP99922192A EP1083171B1 (en) | 1998-05-29 | 1999-05-27 | Pyrazoline derivatives, their preparation and application as medicaments |
BR9910801-1A BR9910801A (pt) | 1998-05-29 | 1999-05-27 | Derivados da pirazolina, a preparação dos mesmose a aplicação dos mesmos como um medicamento |
PL99344412A PL344412A1 (en) | 1998-05-29 | 1999-05-27 | Pyrazoline derivatives, their preparation and application as medicaments |
AU39329/99A AU752001B2 (en) | 1998-05-29 | 1999-05-27 | Pyrazoline derivatives, their preparation and application as medicaments |
SK1807-2000A SK285550B6 (sk) | 1998-05-29 | 1999-05-27 | Derivát pyrazolínu, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje |
NO20006029A NO316600B1 (no) | 1998-05-29 | 2000-11-28 | Pyrazolinderivater, deres fremstilling og anvendelse for fremstilling av legemidler |
LT2000108A LT4879B (lt) | 1998-05-29 | 2000-11-28 | Pirazolino dariniai, jų gavimas ir jų panaudojimas vaistams |
IS5736A IS2040B (is) | 1998-05-29 | 2000-11-28 | Pýrasólínafleiður, framleiðsla þeirra og notkun sem lyfja |
BG105005A BG64950B1 (bg) | 1998-05-29 | 2000-11-29 | Пиразолинови производни, тяхното получаване и приложение като лекарствени средства |
ZA200007638A ZA200007638B (en) | 1998-05-29 | 2000-12-19 | Pyrazoline derivatives, their preparation and application as medicaments. |
CU20000307A CU22995A3 (es) | 1998-05-29 | 2000-12-27 | Derivados de pirazolinas, su preparación y su aplicación como medicamentos |
LVP-00-161A LV12632B (en) | 1998-05-29 | 2000-12-28 | PIRAZOLINE DERIVATIVES, THEIR ACQUISITION AND USE OF MEDICINES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009801129A ES2137138B1 (es) | 1998-05-29 | 1998-05-29 | Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2137138A1 ES2137138A1 (es) | 1999-12-01 |
ES2137138B1 true ES2137138B1 (es) | 2000-09-16 |
Family
ID=8303969
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES009801129A Expired - Lifetime ES2137138B1 (es) | 1998-05-29 | 1998-05-29 | Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos. |
ES99922192T Expired - Lifetime ES2221382T3 (es) | 1998-05-29 | 1999-05-27 | Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES99922192T Expired - Lifetime ES2221382T3 (es) | 1998-05-29 | 1999-05-27 | Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos. |
Country Status (32)
Country | Link |
---|---|
US (2) | US6353117B1 (es) |
EP (1) | EP1083171B1 (es) |
JP (1) | JP4633928B2 (es) |
KR (1) | KR100603666B1 (es) |
CN (1) | CN1189459C (es) |
AR (1) | AR018402A1 (es) |
AT (1) | ATE265437T1 (es) |
AU (1) | AU752001B2 (es) |
BG (1) | BG64950B1 (es) |
BR (1) | BR9910801A (es) |
CA (1) | CA2333475C (es) |
CO (1) | CO5031241A1 (es) |
CU (1) | CU22995A3 (es) |
CZ (1) | CZ298391B6 (es) |
DE (1) | DE69916828T2 (es) |
DK (1) | DK1083171T3 (es) |
ES (2) | ES2137138B1 (es) |
GE (1) | GEP20043237B (es) |
HU (1) | HUP0102102A3 (es) |
IS (1) | IS2040B (es) |
LT (1) | LT4879B (es) |
LV (1) | LV12632B (es) |
NO (1) | NO316600B1 (es) |
NZ (1) | NZ508990A (es) |
PL (1) | PL344412A1 (es) |
PT (1) | PT1083171E (es) |
RU (1) | RU2233272C2 (es) |
SI (1) | SI20580B (es) |
SK (1) | SK285550B6 (es) |
TW (1) | TW572898B (es) |
WO (1) | WO1999062884A1 (es) |
ZA (1) | ZA200007638B (es) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1191931B1 (en) * | 1999-06-16 | 2007-05-09 | Temple University of the Commonwealth System of Higher Education | 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
ES2174757B1 (es) * | 2001-04-06 | 2003-11-01 | Esteve Labor Dr | Empleo de derivados de firazolinas en la elaboracion de un medicamentopara la prevencion y/o el tratamiento de enfermedades proliferativas celulares. |
US20030105144A1 (en) | 2001-04-17 | 2003-06-05 | Ping Gao | Stabilized oral pharmaceutical composition |
US6878729B2 (en) * | 2001-05-04 | 2005-04-12 | The Procter & Gamble Company | Medicinal uses of dihydropyrazoles |
ES2183720B1 (es) * | 2001-06-18 | 2004-01-16 | Esteve Labor Dr | Procedimiento para la preparacion de derivados de 1,5-diaril-3-trifluorometil-delta2-pirazolinas racemicas y enantiomericamente puras. |
DE602004002832T2 (de) | 2003-05-07 | 2007-06-06 | Osteologix A/S | Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen |
ES2238923B1 (es) * | 2004-02-16 | 2006-11-01 | Laboratorios Del Dr. Esteve, S.A. | Nuevos derivados pirazolinicos sustituidos. |
US7998996B2 (en) * | 2004-02-17 | 2011-08-16 | Laboratorios Del Dr. Esteve S.A. | Substituted pyrazoline compounds for reducing triglycerides in blood |
ES2257929B1 (es) * | 2004-07-16 | 2007-05-01 | Laboratorios Del Dr. Esteve, S.A. | Derivados de pirazolina, procedimiento para su obtencion y utilizacion de los mismos como agentes terapeuticos. |
ES2278503B1 (es) * | 2005-06-27 | 2008-06-16 | Laboratorios Del Dr. Esteve, S.A. | Epoxidacion de cetonas alfa, beta - insaturadas. |
WO2007009706A2 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr. Esteve, S.A. | Substituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood |
WO2007009703A2 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr. Esteve, S.A. | New formulations of substituted pyrazoline compounds |
WO2007009699A2 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr. Esteve, S.A | Use of substituted pyrazoline compounds and their derivatives for the treatment of cannabinoid system-associated diseases |
WO2007009693A1 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr.Esteve, S.A | Combination of a substituted pyrazoline compound and a drug used in food-related disorders |
WO2007009704A2 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr. Esteve, S.A. | Use of substituted pyrazoline compounds for the treatment of food disorders, including obesity or metabolic syndrome in patients with developed diabetes |
EP1757587A1 (en) * | 2005-07-15 | 2007-02-28 | Laboratorios Del Dr. Esteve, S.A. | Substituted pyrazoline compounds, their preparation and use as medicaments |
ES2336883B1 (es) * | 2005-07-15 | 2011-03-22 | Laboratorios Del Dr. Esteve, S.A. | Compuestos de pirazolina sustituidos, con una estereoquimica predeterminada, para la reduccion de trigliceridos en sangre. |
EP1743892A1 (en) * | 2005-07-15 | 2007-01-17 | Laboratorios del Dr. Esteve S.A. | Substituted pyrazoline compounds, their preparation and use as medicaments |
EP1743643A1 (en) * | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | New formulations of substituted pyrazoline compounds |
EP1743638A1 (en) * | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | Pharmaceutical formulations of substituted pyrazoline compounds |
EP1849784A1 (en) * | 2006-04-26 | 2007-10-31 | Laboratorios Del Dr. Esteve, S.A. | Indoline-substituted pyrazoline compounds, their preparation and use as medicaments |
WO2007009683A2 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr.Esteve, S.A. | Pharmaceutical formulations of substituted pyrazoline compounds |
EP1743642A1 (en) * | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | Use of substituted pyrazoline compounds and their derivatives for the treatment of cannabinoid system-associated diseases |
WO2007009698A1 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr. Esteve, S.A | Combination of pyrazoline type cannabinoid receptor antagonist and statin |
EP1749526A1 (en) * | 2005-07-15 | 2007-02-07 | Laboratorios Del Dr. Esteve, S.A. | Use of substituted pyrazoline compounds for the treatment of food disorders, including obesity or metabolic syndrome in patients with developed diabetes |
EP1760078A1 (en) * | 2005-07-15 | 2007-03-07 | Laboratorios Del Dr. Esteve, S.A. | Substituted pyrazoline compounds; methods for their preparation |
EP1745781A1 (en) * | 2005-07-15 | 2007-01-24 | Laboratorios Del Dr. Esteve, S.A. | Combination of pyrazoline type cannabinoid receptor antagonist and statin |
WO2007009710A2 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr. Esteve, S.A. | Substituted pyrazoline compounds: methods for their preparation |
WO2007009692A1 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr. Esteve, S.A | Use of substituted pyrazoline compounds for the treatment of food disorders, including obesity or metabolic syndrome in patients with developed diabetes |
EP1743636A1 (en) * | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | Combination of a substituted pyrazoline compound and a drug used in food-related disorders |
AR061623A1 (es) * | 2006-06-26 | 2008-09-10 | Novartis Ag | Derivados de acido fenilacetico |
EP2114461A2 (en) * | 2007-01-19 | 2009-11-11 | Mallinckrodt Inc. | Diagnostic and therapeutic cyclooxygenase-2 binding ligands |
EP3009137A1 (en) * | 2014-10-16 | 2016-04-20 | Ecuphar N.V. | Pyrazoline-derived compound and its use in a weekly dosage regime against inflammation and pain derived from degenerative joint disease in mammals |
EP4029502A1 (en) | 2021-01-15 | 2022-07-20 | Ecuphar N.V. | Pyrazoline-derived compound (enflicoxib) for use in the prevention and/or treatment of pain and inflammation associated to surgery in mammals |
IL305573A (en) | 2021-03-15 | 2023-10-01 | Saul Yedgar | Hyaluronic acid conjugated with dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment or suppression of inflammatory diseases |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2060660B (en) * | 1979-10-18 | 1983-11-23 | Bostik Ltd | Adhesives containing pyrazoline activators |
JPS5818363A (ja) * | 1981-07-13 | 1983-02-02 | アメリカン・サイアナミド・カンパニ− | 複素環式置換アミノピラゾリン類およびその薬としての用途 |
ATE57690T1 (de) * | 1987-01-05 | 1990-11-15 | Du Pont | Pyrazolin mit insektizidischer aktivitaet. |
AU708964B2 (en) * | 1995-05-25 | 1999-08-19 | G.D. Searle & Co. | Method of preparing 3-haloalkyl-1h-pyrazoles |
GB9520584D0 (en) * | 1995-10-09 | 1995-12-13 | Fujisawa Pharmaceutical Co | Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same |
-
1998
- 1998-05-29 ES ES009801129A patent/ES2137138B1/es not_active Expired - Lifetime
-
1999
- 1999-05-27 KR KR1020007013447A patent/KR100603666B1/ko not_active IP Right Cessation
- 1999-05-27 CA CA002333475A patent/CA2333475C/en not_active Expired - Lifetime
- 1999-05-27 SI SI9920042A patent/SI20580B/sl not_active IP Right Cessation
- 1999-05-27 JP JP2000552096A patent/JP4633928B2/ja not_active Expired - Lifetime
- 1999-05-27 CO CO99032824A patent/CO5031241A1/es unknown
- 1999-05-27 GE GEAP19995706A patent/GEP20043237B/en unknown
- 1999-05-27 US US09/701,276 patent/US6353117B1/en not_active Ceased
- 1999-05-27 CN CNB998081116A patent/CN1189459C/zh not_active Expired - Lifetime
- 1999-05-27 AR ARP990102513A patent/AR018402A1/es active IP Right Grant
- 1999-05-27 HU HU0102102A patent/HUP0102102A3/hu unknown
- 1999-05-27 CZ CZ20004418A patent/CZ298391B6/cs not_active IP Right Cessation
- 1999-05-27 PL PL99344412A patent/PL344412A1/xx not_active IP Right Cessation
- 1999-05-27 DK DK99922192T patent/DK1083171T3/da active
- 1999-05-27 AT AT99922192T patent/ATE265437T1/de active
- 1999-05-27 US US10/229,880 patent/USRE38963E1/en not_active Expired - Lifetime
- 1999-05-27 BR BR9910801-1A patent/BR9910801A/pt not_active Application Discontinuation
- 1999-05-27 TW TW88108709A patent/TW572898B/zh not_active IP Right Cessation
- 1999-05-27 WO PCT/ES1999/000156 patent/WO1999062884A1/es active IP Right Grant
- 1999-05-27 EP EP99922192A patent/EP1083171B1/en not_active Expired - Lifetime
- 1999-05-27 ES ES99922192T patent/ES2221382T3/es not_active Expired - Lifetime
- 1999-05-27 RU RU2000133231/04A patent/RU2233272C2/ru not_active IP Right Cessation
- 1999-05-27 NZ NZ508990A patent/NZ508990A/xx unknown
- 1999-05-27 AU AU39329/99A patent/AU752001B2/en not_active Ceased
- 1999-05-27 DE DE69916828T patent/DE69916828T2/de not_active Expired - Lifetime
- 1999-05-27 SK SK1807-2000A patent/SK285550B6/sk unknown
- 1999-05-27 PT PT99922192T patent/PT1083171E/pt unknown
-
2000
- 2000-11-28 IS IS5736A patent/IS2040B/is unknown
- 2000-11-28 LT LT2000108A patent/LT4879B/lt not_active IP Right Cessation
- 2000-11-28 NO NO20006029A patent/NO316600B1/no not_active Application Discontinuation
- 2000-11-29 BG BG105005A patent/BG64950B1/bg unknown
- 2000-12-19 ZA ZA200007638A patent/ZA200007638B/xx unknown
- 2000-12-27 CU CU20000307A patent/CU22995A3/es unknown
- 2000-12-28 LV LVP-00-161A patent/LV12632B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2137138B1 (es) | Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos. | |
ES2187300B1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. | |
AR028988A1 (es) | Derivados amida, proceso para su preparacion, composicion farmaceutica que los comprende, y su uso en la fabricacion de un medicamento util en el tratamiento de enfermedades o afecciones clinicas mediadas por citoquinas | |
ES2054995T3 (es) | Nuevos derivados del acido benzoico y acido fenilacetico, su obtencion y empleo como medicamentos. | |
AR005458A1 (es) | 2-oxo-y 2-tio-1,2-dihidroquinolinil-oxazolidinonas, procedimiento para su produccion, el uso de las mismas para la produccion de un medicamento ymedicamentos que los contienen | |
ECSP055685A (es) | Nuevos compuestos de isotiazol e isoxazol como inhibidores del factor de crecimiento transformador (tgf) | |
ECSP056019A (es) | 2,4-di(fenilamino)pirimidinas útiles en el tratamiento de enfermedades neoplásicas, trastornos inflamatorios y del sistema inmune | |
AR012172A2 (es) | Composiciones farmaceuticas que comprenden analogos de lactacistina y uso de los mismos para la fabricacion de un medicamento | |
ECSP066330A (es) | Derivados de 1-sulfonilindol, su preparación y su uso como lingados de 5-ht-6 | |
ECSP055679A (es) | Derivados de pirazol como inhibidores del factor del crecimiento transformante (tgf) | |
AR004510A1 (es) | Composiciones que comprenden amoxicilina y clavulanato, procedimientos para su preparacion y el uso de las composiciones para la fabricacion de unmedicamento | |
ES2158597T3 (es) | Compuestos bioaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
PA8596801A1 (es) | Derivados de acido acetico sustituido con cicloalquilmetoxi, procedimientos para su preparacion y su uso como farmacos | |
CL2023000086A1 (es) | Análogos de insulina novedosos y usos de estos(div 202201400) | |
AR041891A1 (es) | Empleo de resveratrol para la preparacion de un medicamento util para el tratamiento de infecciones causadas por el virus de la influenza | |
AR001769A1 (es) | Benzamida enterocinética composiciones farmacéuticas que las contienen procedimiento para la preparación de dichas composiciones farmacéuticas el uso de dichos compuestos para la manufactura de medicamentos y un procedimiento para su preparación | |
ECSP22092205A (es) | Composición farmacéutica acuosa de levilimab y su uso | |
AR004726A1 (es) | Derivados 25-hidroxi-16-eno-26,27-bis homo-colecalciferol, compuestos intermediarios para su preparacion, composiciones farmaceuticas que loscontienen y uso de dichos derivados para fabricar un medicamento. | |
SV2001000253A (es) | Pirazolo (4,3-e) diazepinas sustituidas novedosas, composiciones farmaceuticas que las contienen, su uso como productos medicinales y procesos para prepararlas | |
BR112021011368A2 (pt) | Cocristal de cetoprofeno, composições compreendendo o mesmo, processo para a sua produção e usos dos mesmos | |
MX2021006464A (es) | Forma polimorfica de meisoindigo y formulacion modificada de meisoindigo. | |
AR016856A1 (es) | Derivados de camptotecina opticamente puros, compuestos intermedios utilizados para su preparacion, procedimiento para la preparacion de dichos productos intermedios, medicamento y composicion farmaceutica que contienen a dichos derivados de la camptotecina y utilizacion de estos ultimos para prepar | |
SG11201806628UA (en) | New bi-aromatic propynyl compounds, pharmaceutical and cosmetic compositions containing them and uses thereof | |
US11058651B2 (en) | Topical composition for pain relief | |
BR0307723A (pt) | Derivados de benzimidazol substituìdos por 1-fenil-2-heteroarila, seu emprego para preparação de medicamentos bem como preparados farmacêuticos contendo esses derivados |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 19991201 Kind code of ref document: A1 Effective date: 19991201 |
|
PC2A | Transfer of patent |
Owner name: ECUPHAR N.V. Effective date: 20160118 |